Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants

NCT04487405 is registered in ClinicalTrials.gov with Aspira Women's Health as lead sponsor.

NCT NCT04487405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04487405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants
Lead sponsor
Aspira Women's Health
Phase
Observational
Overall status
Terminated
Start date
June 25, 2020
Completion date
December 15, 2023
Enrollment
721 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

adnexal mass